Skip To Main Content
Yinyin Xie on Muck Rack

Yinyin Xie

As seen in: Nature, Wiley Online Library, Frontiers in Immunology, MDPI, Cell Reports Medicine, Dove Medical Press
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Yinyin

Contact Yinyin, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

DPP-4 inhibitors in drug-resistant epilepsy: a hypothesized mechanism via the gut microbiota-short-chain fatty acids-glucagon-like peptide-1 axis

|
By Yinyin Xie, Yi Xie, Aoya Han, Xinru Zhou, Shijie Zhang, Changchang Shen, Yuxuan Zhang, Lina Wang, Xili Fu, Nanchang Xie
| Frontiers in Immunology
Abstract Background: Drug-resistant epilepsy (DRE) affects approximately one-third of patients with epilepsy and remains a major therapeutic challenge.Recent studies have demonstrated significant gut microbiota dysbiosis in patients with DRE, and certain interventions targeting the gut microbiota demonstrate therapeutic efficacy. However, pharmacological interventions that precisely modulate the gut microbiota in DRE have not yet been fully explored.
Open in Who Shared Issue with article?

Aberrant Kupffer-like differentiation of hematopoietic stem cell is critical for the MDS pathogenesis in Setd2 -deficient mice

|
By Fuhui Wang, Yinyin Xie, Xinyue Luo, Hong Tao, Rong Fan, Yan Zhou, Jing Cynthia Wu, Ting Huang, Haifeng Zhao, Xiaojian Sun, Qiuhua Huang, Yuanliang Zhang, Jiachun Song
| Nature Verified
Abstract Histone methyltransferase SETD2 is recurrently mutated in hematopoietic malignancies. Our previous study showed that Setd2 deficiency impairs the self-renewal potential of murine hematopoietic stem cells (HSCs) and drives myelodysplastic syndrome (MDS)-like disorders. However, the precise oncogenic advantages conferred upon HSCs by Setd2 loss remain unclear.
Open in Who Shared Issue with article?

Hypothalamic malate dehydrogenase 2 modulates systemic glucose metabolism through oxytocin-mediated thermogenesis

|
By Ting Yao, Guoming Wu, Yu Zeng, Yinyin Xie, Xiao Cui, Qiongyue Zhang, Zhicheng Cui, Hongyu Gong, Xian Liang, Yan Zhang, Ruiqi Zheng, Hui Wang, Mingchun Gao, Peng Zhang, Ru Wang, Xiao Zhao, Zhihui Feng, Lei Xiao, Tiemin Liu, Zhi Zhang, Chaoying Yan, Tianze Xiong
| Cell Reports Medicine Verified
Keywords malate dehydrogenase 2 MDH2 hypothalamus oxytocin metabolic surgery brown adipose tissue BAT type 2 diabetes T2D sympathetic nervous system SNS Introduction Obesity and type 2 diabetes (T2D) are among the most prevalent chronic metabolic disorders worldwide, severely impacting health and reducing quality of life. Although numerous pharmacological interventions have been developed, safe and effective long-term treatments remain limited.
Open in Who Shared Issue with article?
See all 7 articles